These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1780756)

  • 1. Intensive therapy for adult acute lymphoblastic leukemia.
    Berman E; Weiss M; Kempin S; Gee T; Bertino J; Clarkson B
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):72-5. PubMed ID: 1780756
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
    Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of the treatment of acute lymphocytic leukemia in the adult].
    Shi YD; Zhang ZN
    Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
    Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
    Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
    [No Abstract]   [Full Text] [Related]  

  • 7. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
    Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 12. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
    Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Kudva GC; Chandy M; Dennison D; Srivastava A; Bhushan V
    Indian J Cancer; 1994 Mar; 31(1):1-7. PubMed ID: 8063329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convulsions and intracranial calcifications in a leukemic infant receiving only intrathecal methotrexate as central nervous system prophylaxis.
    Russo A; Di Bella D; Lo Bianco M; Rizzari C; Schilirò G
    Pediatr Hematol Oncol; 1987; 4(3):269-72. PubMed ID: 3152931
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    de Stefano V; Gugliotta L; Mazzucconi MG; Leone G; Mandelli F
    Blood; 1993 May; 81(9):2468-9. PubMed ID: 7683221
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.